Showing posts with label Medicine. Show all posts
Showing posts with label Medicine. Show all posts

Saturday, February 17, 2018

Talks with Iranian President Fruitful : PM Modi

The Prime Minister of India Narendra Modi has termed his talks with Iranian President Hassan Rouhani as fruitful.
India and Iran on Saturday signed nine agreements in different areas after delegation-level talks between PM Modi and President Rouhani in New Delhi. 
The fields in which the agreements were inked include extradition treaty, Chabahar port, medicine and agriculture. 
In a joint statement, Modi said, he had a fruitful discussion with Dr. Rouhani on a wide range of issues of mutual interest. He said, the Iranian President's visit will further deepen and strengthen bilateral ties. 
Modi also said, both countries would like to see a prosperous and terror-free Afghanistan. He said, India and Iran are connected by common Sufi strain and want the region to be free of terror. 
The Prime Minister also thanked Mr Rouhani for providing leadership in developing Chabahar Port which is a gateway to Central Asia.
Both leaders also released a special postal stamp. Earlier in the day, External Affairs Minister Sushma Swaraj called on the visiting dignitary and discussed ways to strengthen co-operation in energy, connectivity, IT, education, culture and people-to-people contact. 
The Iranian President was accorded a ceremonial reception at Rashtrapati Bhawan Saturday morning. He also visited Rajghat to pay tributes to Father of the Nation Mahatma Gandhi.
Rouhani will meet President Ram Nath Kovind and Vice President M Venkaiah Naidu later on Saturday.
The Iranian President, who is on three-day visit to India, arrived in New Delhi last night after his stay in Hyderabad.

Monday, March 06, 2017

NCL and IGIB Sign Licensing Agreement with Ahammune Biosciences for Vitiligo Drug Development

CSIR-National Chemical Laboratory (CSIR-NCL), Pune and CSIR- Institute of Genomics and Integrative Biology (CSIR-IGIB), New Delhi together signed a Patent Licensing agreement with Ahammune Biosciences Pvt. Ltd., Pune for Vitiligo drug development on March 2, 2017. Ahammune is a resident incubatee company of Venture Center, NCL’s technology business incubator.

Ahammune Biosciences is an innovation-led drug discovery start-up company with the vision to find a new drug for the debilitating skin disorder, Vitiligo. It is the most common depigmenting disease with over 80 million people affected by it. In Vitiligo, color-producing cells are lost from areas of skin leaving behind white spots. The spread of depigmentation is unpredictable, ranging from days to years. Due to its effect on physical appearance, it is a cause of immense psychological torment, with patients feeling isolated and depressed. This disease is of major concern in India, where it is considered as a social stigma due to its confusion with leprosy. The current treatment strategies provide only temporary relief and are mostly ineffective. Ahammune is striving to fulfil this unmet medical need in the vitiligo therapeutic area.

Ahammune Biosciences would like to conduct further work towards potential vitiligo drug development through this Licensing agreement. CSIR labs will receive milestone payments based on the progress.

The patent was the outcome of the collaborative research work in chemistry and biology between these two labs. Dr. D. Srinivasa Reddy (CSIR-NCL), Dr. Rajesh S. Gokhale (CSIR-IGIB, on deputation from NII) and T. N. Vivek (CSIR-IGIB) are the lead inventors of the patent.

Prof. Ashwini Kumar Nangia, Director, CSIR-NCL and Dr. (Miss.) Parul Ganju, Director, Ahammune Biosciences Pvt. Ltd. signed the agreement in presence of respective teams from both parties.

Saturday, January 17, 2009

HAL employees to get Fifth Pay Commission

The Union Minister for Chemicals & Fertilizers Ramvilas Paswan announced on Saturday that revised pay scales according to Justice Mohan Commiittee recommendations on 5th Pay Commission would be applicable to Hindustan Antibiotics employees from 17 Jan 2009.The arrears from 1997 would be given in instalments in due course of time and the timetable for arrears distribution would be discussed with the HAL Employees Unions. Every employee will also get Rs 1000 as bonus in the new year.

Paswan was speaking at the inauguration of the new Cephalosporin plant of HAL in Pimpri today. The HAL Union General Secretary Shri Pataskar said that employees were working on the same salary since 1992 and badly needed the pay hike. Mahatma's wife Smt Kasturba Gandhi died in Pune after she could not get the required medicines after which Nehru in 1954 had announced setting up of Hindustan Antibiotics. Selling such cos and not turning them around was wrong as was done during Arun Shourie's time. 

The plant has been set up at a cost of Rs 20.17 crores  in a record 9 months time and will enable the company to manufacture the new generation antibiotic for the domestic & international market. The immediate application of new pay scales would increase the salaries of employees by roughly 25 percent and the benefits would be in the range of Rs 1500-8000 depending on the level of the employees.